UniProt ID | KC1G1_HUMAN | |
---|---|---|
UniProt AC | Q9HCP0 | |
Protein Name | Casein kinase I isoform gamma-1 | |
Gene Name | CSNK1G1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 422 | |
Subcellular Localization | Cytoplasm. | |
Protein Description | Serine/threonine-protein kinase. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. It can phosphorylate a large number of proteins. Participates in Wnt signaling. Regulates fast synaptic transmission mediated by glutamate (By similarity). Phosphorylates CLSPN.. | |
Protein Sequence | MDHPSREKDERQRTTKPMAQRSAHCSRPSGSSSSSGVLMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPIKSRAPQLHLEYRFYKQLGSAGEGLPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFTLKTVLMIAIQLLSRMEYVHSKNLIYRDVKPENFLIGRQGNKKEHVIHIIDFGLAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRNTPIEALCENFPEEMATYLRYVRRLDFFEKPDYEYLRTLFTDLFEKKGYTFDYAYDWVGRPIPTPVGSVHVDSGASAITRESHTHRDRPSQQQPLRNQVVSSTNGELNVDDPTGAHSNAPITAHAEVEVVEEAKCCCFFKRKRKKTAQRHK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
14 | Phosphorylation | EKDERQRTTKPMAQR HHHHHHHCCCCHHHH | 30.73 | - | |
15 | Phosphorylation | KDERQRTTKPMAQRS HHHHHHCCCCHHHHH | 35.03 | - | |
22 | Phosphorylation | TKPMAQRSAHCSRPS CCCHHHHHHHCCCCC | 15.41 | 27422710 | |
26 | Phosphorylation | AQRSAHCSRPSGSSS HHHHHHCCCCCCCCC | 37.04 | 29449344 | |
29 | Phosphorylation | SAHCSRPSGSSSSSG HHHCCCCCCCCCCCC | 50.63 | 27422710 | |
31 | Phosphorylation | HCSRPSGSSSSSGVL HCCCCCCCCCCCCEE | 31.24 | 21712546 | |
32 | Phosphorylation | CSRPSGSSSSSGVLM CCCCCCCCCCCCEEE | 37.45 | 29449344 | |
33 | Phosphorylation | SRPSGSSSSSGVLMV CCCCCCCCCCCEEEE | 30.16 | 28555341 | |
34 | Phosphorylation | RPSGSSSSSGVLMVG CCCCCCCCCCEEEEC | 32.81 | 29449344 | |
35 | Phosphorylation | PSGSSSSSGVLMVGP CCCCCCCCCEEEECC | 34.56 | 29449344 | |
49 | Ubiquitination | PNFRVGKKIGCGNFG CCCCCCCEECCCCCC | 38.10 | - | |
62 | Ubiquitination | FGELRLGKNLYTNEY CCEEECCCCCCCCCE | 48.66 | - | |
65 | Phosphorylation | LRLGKNLYTNEYVAI EECCCCCCCCCEEEE | 19.53 | 28152594 | |
66 | Phosphorylation | RLGKNLYTNEYVAIK ECCCCCCCCCEEEEE | 25.41 | 28152594 | |
69 | Phosphorylation | KNLYTNEYVAIKLEP CCCCCCCEEEEEEEE | 9.39 | 28152594 | |
88 | Phosphorylation | APQLHLEYRFYKQLG CCCHHHHHHHHHHHC | 16.63 | 20071362 | |
91 | Phosphorylation | LHLEYRFYKQLGSAG HHHHHHHHHHHCCCC | 6.71 | 20071362 | |
96 | Phosphorylation | RFYKQLGSAGEGLPQ HHHHHHCCCCCCCCE | 41.51 | - | |
135 | Phosphorylation | LFDLCDRTFTLKTVL HHHHHCCCCHHHHHH | 14.02 | 20068231 | |
137 | Phosphorylation | DLCDRTFTLKTVLMI HHHCCCCHHHHHHHH | 27.08 | - | |
140 | Phosphorylation | DRTFTLKTVLMIAIQ CCCCHHHHHHHHHHH | 23.22 | - | |
162 | Phosphorylation | VHSKNLIYRDVKPEN HHHCCEECCCCCHHH | 12.15 | - | |
166 | Ubiquitination | NLIYRDVKPENFLIG CEECCCCCHHHEEEE | 51.40 | - | |
194 | Phosphorylation | DFGLAKEYIDPETKK ECCCCHHHCCHHHHC | 15.21 | - | |
217 | Phosphorylation | SLTGTARYMSINTHL CCCCCCEEEEHHHHC | 7.86 | 29496907 | |
255 | Ubiquitination | SLPWQGLKADTLKER CCCCCCCCHHHHHHH | 51.55 | 21890473 | |
255 (in isoform 1) | Ubiquitination | - | 51.55 | 21890473 | |
255 (in isoform 2) | Ubiquitination | - | 51.55 | 21890473 | |
255 | Ubiquitination | SLPWQGLKADTLKER CCCCCCCCHHHHHHH | 51.55 | - | |
258 | Phosphorylation | WQGLKADTLKERYQK CCCCCHHHHHHHHHH | 44.59 | 17192257 | |
263 | Phosphorylation | ADTLKERYQKIGDTK HHHHHHHHHHHCCCC | 18.43 | 18083107 | |
265 | Ubiquitination | TLKERYQKIGDTKRN HHHHHHHHHCCCCCC | 39.46 | - | |
273 | Phosphorylation | IGDTKRNTPIEALCE HCCCCCCCHHHHHHH | 29.67 | 24114839 | |
288 | Phosphorylation | NFPEEMATYLRYVRR CCCHHHHHHHHHHHH | 23.06 | 22210691 | |
289 | Phosphorylation | FPEEMATYLRYVRRL CCHHHHHHHHHHHHC | 4.61 | 24114839 | |
309 | Phosphorylation | PDYEYLRTLFTDLFE CCHHHHHHHHHHHHH | 24.51 | - | |
317 | Ubiquitination | LFTDLFEKKGYTFDY HHHHHHHHCCCEEEE | 44.13 | 2190698 | |
317 (in isoform 1) | Ubiquitination | - | 44.13 | 21890473 | |
317 (in isoform 2) | Ubiquitination | - | 44.13 | 21890473 | |
344 | Phosphorylation | VGSVHVDSGASAITR CEEEEECCCCCEECC | 34.86 | 17192257 | |
347 | Phosphorylation | VHVDSGASAITRESH EEECCCCCEECCCCC | 24.59 | 18691976 | |
361 | Phosphorylation | HTHRDRPSQQQPLRN CCCCCCCHHCCCCHH | 41.33 | 21082442 | |
373 | Phosphorylation | LRNQVVSSTNGELNV CHHHHHHCCCCCCCC | 17.81 | 23663014 | |
374 | Phosphorylation | RNQVVSSTNGELNVD HHHHHHCCCCCCCCC | 39.47 | 23663014 | |
411 | Ubiquitination | AKCCCFFKRKRKKTA HEEEEEEHHHCHHHH | 36.44 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of KC1G1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of KC1G1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of KC1G1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
WDCP_HUMAN | C2orf44 | physical | 21900206 | |
IKZF1_HUMAN | IKZF1 | physical | 21900206 | |
F219A_HUMAN | FAM219A | physical | 21900206 | |
MKRN1_HUMAN | MKRN1 | physical | 21900206 | |
RUN3B_HUMAN | RUNDC3B | physical | 21900206 | |
A4_HUMAN | APP | physical | 21832049 | |
TRAF6_HUMAN | TRAF6 | physical | 24442433 | |
TF65_HUMAN | RELA | physical | 24442433 | |
CEP76_HUMAN | CEP76 | physical | 25416956 | |
KR107_HUMAN | KRTAP10-7 | physical | 25416956 | |
KC1G2_HUMAN | CSNK1G2 | physical | 26186194 | |
KC1G2_HUMAN | CSNK1G2 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-344 AND SER-361, ANDMASS SPECTROMETRY. |